Skip to content

Clinical trials

Phase 2 Kidney Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Neoplasms Phase: Phase 2 Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20181
20231
20245
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Not yet recruiting2
Unknown status2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University2
Jinling Hospital, China2
RenJi Hospital2
Fuda Cancer Hospital, Guangzhou1
Huabo Biopharm Co., Ltd.1
Sichuan Baili Pharmaceutical Co., Ltd.1
Sun Yat-sen University1
West China Hospital1
YongZhang1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Neoplasms12
Carcinoma, Renal Cell5
Acute Kidney Injury1
Angiomyolipoma1
Basal Cell Carcinoma1
Breast Neoplasms1
Carcinoma1
Carcinoma, Neuroendocrine1
Carcinoma, Transitional Cell1
Colorectal Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.